GSK is recalling two specific batches of Ventolin (salbutamol) 200mcg Accuhaler devices from patients and one specific batch of Seretide (salmeterol xinafoate, fluticasone propionate) 50/250mcg Accuhaler devices from hospitals, pharmacies, dispensing practices, retailers and wholesalers.

The action follows a manufacturing issue that the pharma giant says may result in a small number of Accuhaler devices not delivering the full number of doses in the device.

No other GSK inhalers are affected by this issue, the company maintains, and says it is important to note, the more commonly used ‘boot’-shaped Ventolin Evohaler ‘rescue’ inhaler is not affected by the recall. 

The two Lots of Ventolin Accuhaler being recalled are: 786G and 754P. The one Lot of Seretide Accuhaler devices from hospitals, pharmacies, dispensing practices, retailers and wholesalers being recalled is 5K8W.

 

GSK's full statement is available here.

Recommended

Diabetes UK gives tips on promoting conversation around the condition

Diabetes UK has produced a list of top tips for health professionals to encourage people with diabetes to have conversat...

Pharmacists could save NHS £6m on infant GI disorders

New research has found that pharmacists could save the NHS millions of pounds and improve care for infants with reflux, ...


By using this website, you accept Independent Pharmacist Terms of Use, Privacy Policy and Cookie Policy. Click accept to hide box. By continuing browsing you have confirmed your acceptance.